Literatur
Yu X, White KE (2005) FGF23 and disorders of phosphate homeostasis. Cytokine Growth Factor Rev 16: 221–232
Quigley R (2006) Proximal renal tubular acidosis. J Nephrol 19 [Suppl 9]: S41–S45
Scheinman SJ, Guay-Woodford LM, Thakker RV, Warnock DG (1999) Genetic disorders of renal electrolyte transport. N Engl J Med 340: 1177–1187
Yang CL, Angell J, Mitchell R, Ellison DH (2003) WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111: 1039–1045
Mattsson C, Young WF Jr (2006) Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol 2: 198–208; quiz, 191 p following 230
Garovic VD, Hilliard AA, Turner ST (2006) Monogenic forms of low-renin hypertension. Nat Clin Pract Nephrol 2: 624–630
Ferrari P, Lovati E, Frey FJ (2000) The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. J Hypertens 18: 241–248
Hebert LA (2006) Optimizing ACE-inhibitor therapy for chronic kidney disease. N Engl J Med 354: 189–191
Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 351: 543–551
Schrier RW (2006) Body water homeostasis: clinical disorders of urinary dilution and concentration. J Am Soc Nephrol 17: 1820–1832
Clarkson MR, Giblin L, O'Connell FP, O'Kelly P, Walshe JJ, Conlon P, O'Meara Y, Dormon A, Campbell E, Donohoe J (2004) Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrol Dial Transplant 19: 2778–2783
Choudhury D, Ahmed Z (2006) Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol 2: 80–91
Muranyi W, Bahr U, Zeier M, van der Woude FJ (2005) Hantavirus infection. J Am Soc Nephrol 16: 3669–3679
Mihatsch MJ, Khanlari B, Brunner FP (2006) Obituary to analgesic nephropathy – an autopsy study. Nephrol Dial Transplant 21: 3139–3145
Feinstein AR, Heinemann LA, Curhan GC, Delzell E, Deschepper PJ, Fox JM, Graf H, Luft FC, Michielsen P, Mihatsch MJ, Suissa S, Van Der Woude F, Willich S (2000) Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int 58: 2259–2264
Bogdanova N, Markoff A, Horst J (2002) Autosomal dominant polycystic kidney disease – clinical and genetic aspects. Kidney Blood Press Res 25: 265–283
Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP (2006) Volume progression in polycystic kidney disease. N Engl J Med 354: 2122–2130
Zhang Q, Taulman PD, Yoder BK (2004) Cystic kidney diseases: all roads lead to the cilium. Physiology (Bethesda) 19: 225–230
Walz G (2006) Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel? Nephrol Dial Transplant 21: 1752–1757
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lhotta, K. Tubuläre Nierenerkrankungen. wkw education 2, 59–71 (2007). https://doi.org/10.1007/s11812-007-0023-z
Issue Date:
DOI: https://doi.org/10.1007/s11812-007-0023-z